Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoMACS: Metadate CD vs Concerta in Pediatric ADHD
NCT00381758Phase 4Completed
- Sponsor
- UCB
- Start
- May 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by UCB. Primary endpoint: Swanson Kotkin Agler MFlynn Pelham ADHD Rating Scale Deportment Items at 7.5 hours. Started May 2002; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00381758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381758.